These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27555429)

  • 21. Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials.
    Rothman M; Vallow S; Damaraju CV; Hewitt DJ
    Curr Med Res Opin; 2009 Jun; 25(6):1433-43. PubMed ID: 19419336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based Survey.
    Nguyen VT; Ravaud P; Tran VT; Young B; Boutron I
    J Med Internet Res; 2022 Feb; 24(2):e29691. PubMed ID: 35103603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    Hofheinz R; Clouth J; Borchardt-Wagner J; Wagner U; Weidling E; Jen MH; Brück P
    BMC Cancer; 2016 Dec; 16(1):937. PubMed ID: 27923357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electronic diaries as a tool to improve pain management: is there any evidence?
    Marceau LD; Link C; Jamison RN; Carolan S
    Pain Med; 2007 Oct; 8 Suppl 3():S101-9. PubMed ID: 17877520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient and parent preferences for immunoglobulin treatments: a conjoint analysis.
    Mohamed AF; Kilambi V; Luo MP; Iyer RG; Li-McLeod JM
    J Med Econ; 2012; 15(6):1183-91. PubMed ID: 22846048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations.
    Smith SM; Wang AT; Katz NP; McDermott MP; Burke LB; Coplan P; Gilron I; Hertz SH; Lin AH; Rappaport BA; Rowbotham MC; Sampaio C; Sweeney M; Turk DC; Dworkin RH
    Pain; 2013 Jul; 154(7):997-1008. PubMed ID: 23602344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early phase drug development for treatment of chronic pain--options for clinical trial and program design.
    Kalliomäki J; Miller F; Kågedal M; Karlsten R
    Contemp Clin Trials; 2012 Jul; 33(4):689-99. PubMed ID: 22401888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reporting of cross-over clinical trials of analgesic treatments for chronic pain: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review and recommendations.
    Gewandter JS; McDermott MP; McKeown A; Hoang K; Iwan K; Kralovic S; Rothstein D; Gilron I; Katz NP; Raja SN; Senn S; Smith SM; Turk DC; Dworkin RH
    Pain; 2016 Nov; 157(11):2544-2551. PubMed ID: 27437786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Day-to-Day Changes of Auricular Point Acupressure to Manage Chronic Low Back Pain: A 29-day Randomized Controlled Study.
    Yeh CH; Kwai-Ping Suen L; Chien LC; Margolis L; Liang Z; Glick RM; Morone NE
    Pain Med; 2015 Oct; 16(10):1857-69. PubMed ID: 25988270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of app-based relaxation for patients with chronic low back pain (Relaxback) and chronic neck pain (Relaxneck): study protocol for two randomized pragmatic trials.
    Blödt S; Pach D; Roll S; Witt CM
    Trials; 2014 Dec; 15():490. PubMed ID: 25511185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons.
    Ney JP; Devine EB; Watanabe JH; Sullivan SD
    Pain Med; 2013 May; 14(5):706-19. PubMed ID: 23691937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
    Smith SM; Dworkin RH; Turk DC; McDermott MP; Eccleston C; Farrar JT; Rowbotham MC; Bhagwagar Z; Burke LB; Cowan P; Ellenberg SS; Evans SR; Freeman RL; Garrison LP; Iyengar S; Jadad A; Jensen MP; Junor R; Kamp C; Katz NP; Kesslak JP; Kopecky EA; Lissin D; Markman JD; Mease PJ; O'Connor AB; Patel KV; Raja SN; Sampaio C; Schoenfeld D; Singh J; Steigerwald I; Strand V; Tive LA; Tobias J; Wasan AD; Wilson HD
    Pain; 2020 Nov; 161(11):2446-2461. PubMed ID: 32520773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
    Siegenthaler A; Schliessbach J; Vuilleumier PH; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    BMC Pharmacol Toxicol; 2015 Sep; 16():23. PubMed ID: 26376691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What influences participants' treatment preference and can it influence outcome? Results from a primary care-based randomised trial for shoulder pain.
    Thomas E; Croft PR; Paterson SM; Dziedzic K; Hay EM
    Br J Gen Pract; 2004 Feb; 54(499):93-6. PubMed ID: 14965386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferences for psychological therapy in psychosis: trial participation, mode of treatment, and willingness to be randomised.
    Sumner K; Haddock G; Hartley S; Kilbride M; McCusker M; Pitt L; Woodward S; Barrowclough C
    J Ment Health; 2014 Apr; 23(2):67-71. PubMed ID: 24328784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An exploration of participants' treatment preferences in a partial RCT.
    Miranda J
    Can J Nurs Res; 2004 Sep; 36(3):100-14. PubMed ID: 15551665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
    Edwards RR; Dworkin RH; Turk DC; Angst MS; Dionne R; Freeman R; Hansson P; Haroutounian S; Arendt-Nielsen L; Attal N; Baron R; Brell J; Bujanover S; Burke LB; Carr D; Chappell AS; Cowan P; Etropolski M; Fillingim RB; Gewandter JS; Katz NP; Kopecky EA; Markman JD; Nomikos G; Porter L; Rappaport BA; Rice ASC; Scavone JM; Scholz J; Simon LS; Smith SM; Tobias J; Tockarshewsky T; Veasley C; Versavel M; Wasan AD; Wen W; Yarnitsky D
    Pain; 2016 Sep; 157(9):1851-1871. PubMed ID: 27152687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial.
    Nenke MA; Haylock CL; Rankin W; Inder WJ; Gagliardi L; Eldridge C; Rolan P; Torpy DJ
    Psychoneuroendocrinology; 2015 Jun; 56():157-67. PubMed ID: 25827960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain.
    McHugh RK; Weiss RD; Cornelius M; Martel MO; Jamison RN; Edwards RR
    J Pain; 2016 Jul; 17(7):806-14. PubMed ID: 27058161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations.
    Gewandter JS; McDermott MP; McKeown A; Smith SM; Williams MR; Hunsinger M; Farrar J; Turk DC; Dworkin RH
    Pain; 2014 Sep; 155(9):1871-1877. PubMed ID: 24993384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.